Cooperative Agreement 2P2CMS332035
- The North Carolina Department of Health and Human Services (NC DHHS) was awarded a $558,941 cooperative agreement from the Centers for Medicare and Medicaid Services (CMS) under the Cell and Gene Therapy (CGT) Access Model program (CFDA 93.885). The funding will support a set of activities aimed at ensuring the successful implementation of the CGT Access Model in North Carolina, with the overarching goal of strengthening the state's capacity to provide access to cell and gene therapies for...
- The Department of Health Care Finance (DHCF), the District of Columbia's state Medicaid agency, was awarded a $7,072,261 cooperative agreement by the Centers for Medicare and Medicaid Services (CFDA #93.885 Cell and Gene Therapy (CGT) Access Model) on August 1, 2025. The funding will support DHCF's implementation of the CGT Access Model, which aims to improve access to cell and gene therapies, particularly for sickle cell disease patients. The grant will enable DHCF to: 1) build internal...
- The Illinois Department of Healthcare and Family Services (HFS) was awarded a $794,800 Cooperative Agreement under the Centers for Medicare and Medicaid Services' (CMS) Cell and Gene Therapy (CGT) Access Model (CFDA 93.885). The award will fund HFS staff to implement the CGT Access Model, conduct research to evaluate Medicaid customer access to sickle cell disease CGTs and the effectiveness of wraparound services, and support Community-Based Organizations (CBOs) to provide education,...
- The Pennsylvania Department of Human Services (DHS) received a $4,536,712.42 Cooperative Agreement award from the Centers for Medicare and Medicaid Services (CMS) under the Section 206 Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid & CHIP Beneficiaries program (CFDA 93.694). The funding will support a four-year project to implement an electronic health record (EHR) system across eight juvenile justice facilities operated by DHS. The...
- The Mississippi Division of Medicaid (DOM) was awarded a $4,912,944 Cooperative Agreement from the Centers for Medicare and Medicaid Services (CFDA 93.885 - Cell and Gene Therapy (CGT) Access Model) to transform healthcare for Medicaid beneficiaries living with sickle cell disease. The funding will support five key initiatives over a 10-year period from August 2025 to December 2035: 1) Travel support for patients and caregivers to access treatment, 2) Individualized care coordination to guide...
- The Rhode Island Executive Office of Health and Human Services (EOHHS) was awarded a $793,419.04 Cooperative Agreement under the Centers for Medicare and Medicaid Services' (CMS) Cell and Gene Therapy (CGT) Access Model federal grant program (CFDA 93.885). The funding will be used to enhance access to cell and gene therapies and improve care for individuals with sickle cell disease in Rhode Island through a comprehensive, multi-faceted approach. Key activities include developing evidence-based...
- The Pennsylvania Department of Human Services (PA DHS) was awarded a $294,590 Formula Grant under the U.S. Department of Health and Human Services Administration for Children and Families' Grants to States for Access and Visitation Programs (CFDA 93.597). The grant, effective October 1, 2023 through September 30, 2025, will enable PA DHS to create programs supporting and facilitating access and visitation by non-custodial parents with their children. Funded activities may include mediation,...
- The federal Project Grant award in the amount of $503,870.00 was provided by the National Heart, Lung, and Blood Institute (CFDA Program 93.837 - Cardiovascular Diseases Research) to Drexel University. The award is focused on developing a mechanistic understanding of how fetal hemoglobin (HbF) modulates the polymerization of sickle cell hemoglobin (HbS), which is the root cause of sickle cell disease. The research aims to address critical knowledge gaps that limit the rational optimization of...
- The Department of Health and Human Services Centers for Medicare and Medicaid Services awarded the Pennsylvania Department of Human Services a $1.116 million Formula Grant under the Medical Assistance Program (CFDA 93.778) for the period of April 1, 2021 through June 30, 2021. The grant funding supports Pennsylvania's provision of medical assistance on behalf of cash assistance recipients, children, pregnant women, and the aged who meet income and resource requirements, as well as other...
- This $171,979,291 Formula Grant award from the Department of Health and Human Services Administration for Children and Families provides funding through September 30, 2023 for the Social Services Block Grant (CFDA 93.667) program. The grant supports the Pennsylvania Department of Human Services in administering funds to seven sub-awardees to deliver social services across Pennsylvania. Sub-awardees include the Pennsylvania Coalition Against Domestic Violence, Pennsylvania Coalition Against Rape,...
The Pennsylvania Department of Human Services (DHS) was awarded a $794,800 Cooperative Agreement from the Centers for Medicare and Medicaid Services (CMS) under the federal Cell and Gene Therapy (CGT) Access Model program (CFDA 93.885). The funding will be used to provide additional services, education, and supports for Medicaid beneficiaries who may be candidates for sickle cell disease gene therapy. DHS will collaborate with the Pennsylvania Department of Health's Sickle Cell Disease Community-Based Services and Support (CBSS) program and partner with community-based organizations to improve opportunities, access, and awareness of sickle cell disease gene therapies for Medicaid beneficiaries. The project period runs from August 1, 2025 to December 31, 2035.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $794.8k | 8/1/25 |